One essay a month, sometimes two. Never more. No promo. Long-form on ovarian biology, the broken value chain, and the venture opportunities at every bottleneck.
How recognizing your body's most undervalued assets could change everything about aging.
And why you should care.
The model-organism problem at the heart of reproductive aging research. And the biotech opportunity hiding in it.
A measured case for therapeutic intervention over personal optimization. Why n=1 isn't enough.
McKinsey says closing the women's health gap is worth a trillion dollars. The capital can't find the founders. Here's why.
The long shadow of excluding women from clinical research. What changed, what didn't, and what to ask before enrolling.
If one organ ages decades faster than the rest, it's probably driving the rest. The case for ovary-as-pacemaker.
Epigenetic clocks show biological age rises during pregnancy then rebounds below baseline. What that tells us about plasticity.
The papers, books, and primary sources I send people who want to actually understand the field. Updated quarterly.